| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD008394 |
| P8608 | Fatcat ID | release_mreatip73rbzbiinyvt4ffwexm |
| P50 | author | Arturo J Martí-Carvajal | Q28036555 |
| Maria José Martinez-Zapata | Q28323568 | ||
| Jennifer M Knight-Madden | Q87922286 | ||
| P2860 | cites work | Dressings for superficial and partial thickness burns | Q24241282 |
| Compression for venous leg ulcers | Q24241720 | ||
| Debridement for surgical wounds | Q24242661 | ||
| Antibiotics and antiseptics for venous leg ulcers | Q24242699 | ||
| Silver based wound dressings and topical agents for treating diabetic foot ulcers | Q24244672 | ||
| Dressings for healing venous leg ulcers | Q24245278 | ||
| Wound cleansing for pressure ulcers | Q24245433 | ||
| Skin grafting for venous leg ulcers | Q24245550 | ||
| Dressings and topical agents for surgical wounds healing by secondary intention | Q24247419 | ||
| Why Most Discovered True Associations Are Inflated | Q24273233 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Laser therapy for venous leg ulcers. | Q30867971 | ||
| Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers | Q30871066 | ||
| Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain | Q33332124 | ||
| High prevalence of pulmonary hypertension in homozygous sickle cell patients with leg ulceration. | Q51660654 | ||
| Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. | Q51896675 | ||
| Genetic etiologies for phenotypic diversity in sickle cell anemia. | Q54941772 | ||
| Social effects of leg ulceration in sickle cell anemia | Q67552856 | ||
| Treatment of sickle cell leg ulcers with pentoxifylline | Q68834289 | ||
| L-carnitine for leg ulcers | Q68880741 | ||
| Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study | Q69715478 | ||
| Topical antibiotics in chronic sickle cell leg ulcers | Q69826773 | ||
| Bacteriology of sickle cell leg ulcers | Q70325344 | ||
| Leg ulcers in sickle cell disease | Q71861751 | ||
| Does diet or alcohol explain the French paradox | Q72559525 | ||
| Molgramostim to treat SS-sickle cell leg ulcers | Q72559527 | ||
| Healing of chronic sicklemia leg ulcers healed by cortisone | Q73280329 | ||
| Human skin equivalent in the treatment of chronic leg ulcers in sickle cell disease patients | Q73413624 | ||
| Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study | Q73727188 | ||
| Impaired venous hemodynamics in a minority of patients with chronic leg ulcers due to sickle cell anemia | Q77433509 | ||
| Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence | Q78445520 | ||
| Oral zinc sulphate in sickle-cell ulcers | Q93691263 | ||
| Oral zinc for arterial and venous leg ulcers. | Q33909151 | ||
| Compression for preventing recurrence of venous ulcers. | Q34062384 | ||
| Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting | Q34321385 | ||
| Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes | Q34579250 | ||
| Sickle cell disease vasculopathy: a state of nitric oxide resistance | Q34747999 | ||
| Neonatal screening for sickle cell disease in France. | Q34909712 | ||
| Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions | Q34992760 | ||
| Debridement of diabetic foot ulcers. | Q35041888 | ||
| Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway | Q35191429 | ||
| Neonatal screening for sickle cell disorders. | Q35626383 | ||
| Redox-dependent impairment of vascular function in sickle cell disease | Q36274222 | ||
| Leg ulceration in sickle cell disease: medieval medicine in a modern world | Q36281550 | ||
| Sickle cell disease and nitric oxide: a paradigm shift? | Q36381179 | ||
| Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels | Q36515494 | ||
| Sickle cell disease in Africa: burden and research priorities | Q36715984 | ||
| Postural vasoconstriction and leg ulceration in homozygous sickle cell disease | Q36849445 | ||
| Sickle cell disease: current activities, public health implications, and future directions | Q36879110 | ||
| Global epidemiology of haemoglobin disorders and derived service indicators | Q37108897 | ||
| Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies | Q37191726 | ||
| Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease | Q37330977 | ||
| Mechanisms of vasculopathy in sickle cell disease and thalassemia | Q37346716 | ||
| Neonatal haemoglobinopathy screening in Spain | Q37356764 | ||
| Assessment of risk of bias in randomized clinical trials in surgery | Q37414132 | ||
| Are there clinical phenotypes of homozygous sickle cell disease? | Q38868234 | ||
| Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia | Q38957756 | ||
| Microbial flora and its significance in pathology of sickle cell disease leg ulcers | Q39190343 | ||
| Rapid healing of a late diagnosed sickle cell leg ulcer using a new combination of treatment methods | Q39436734 | ||
| Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease | Q39512160 | ||
| Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. | Q40520732 | ||
| Perfect study, poor evidence: interpretation of biases preceding study design | Q43872521 | ||
| Treatment of painful sickle cell leg ulcers with topical opioids | Q43873247 | ||
| Neonatal screening for hemoglobinopathies: a pilot study in Porto Alegre, Rio Grande do Sul, Brazil | Q44017145 | ||
| Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies | Q44175069 | ||
| Venous insufficiency is not the cause of leg ulcers in sickle cell disease | Q44425258 | ||
| Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers. | Q46451640 | ||
| Topical GM-CSF hastens healing of leg ulcers in sickle cell disease | Q47426329 | ||
| Leg ulcers in sickle cell disease. | Q51597006 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P577 | publication date | 2010-03-17 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Interventions for treating leg ulcers in people with sickle cell disease |
Search more.